ALP Bio AG
PrivateLast Round
Pre Seed
Apr 30, 2026
Total Funding Raised
$2.2M
Company Overview
ALP Bio AG is a biotechnology company developing an immune organoid and AI platform for immunogenicity intelligence in biologics development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, ML Platforms
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ALP Bio AG Comps
Public and private peers based on sector, stage, and business model.
ALP Bio AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Apr 30, 2026 |
ALP Bio AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 42CAP | Pre Seed |
| Venture Kick | Pre Seed |
| Ajira Ventures | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 30, 2026
$2.2M round led by 42CAP.
ALP Bio AG Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ALP Bio AG's valuation, stock price, and market status.
